SanofiSNYNASDAQ
Loading
EBITDA as a percentage of revenue
3Y CAGR
-6.6%/yr
vs +6.7%/yr prior
5Y CAGR
-10.7%/yr
Recent acceleration
Acceleration
-13.3pp
Decelerating
Percentile
P21
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 27.14% | +8.9% |
| 2024 | 24.91% | -9.0% |
| 2023 | 27.37% | -17.8% |
| 2022 | 33.31% | +13.1% |
| 2021 | 29.45% | -38.5% |
| 2020 | 47.86% | +68.9% |
| 2019 | 28.33% | +10.1% |
| 2018 | 25.73% | -3.3% |
| 2017 | 26.61% | -6.8% |
| 2016 | 28.53% | - |